Older Americans' Preferences Between Lower Drug Prices and Prescription Drug Plan Choice, 2019.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 31944838.
- Also identified by DOI 10.2105/AJPH.2019.305483 and PMC identifier 7002957.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<i>Objectives.</i> To assess older Americans' willingness to trade off the possibility of choosing or changing their prescription drug plan for lower drug spending.<i>Methods.</i> We used data from the Kaiser Family Foundation Health Tracking Poll on prescription drugs carried out in February 2019. This nationwide telephone survey oversampled participants aged 65 years and older who, when weighted, were representative of the US older adult population.<i>Results.</i> Older adults were strongly in favor of the government negotiating drug prices in Medicare Part D (82% support); 60% of older adults would trade off the possibility of choosing or switching their drug plan in favor of lower drug prices. All groups preferred lower spending over plan choice, but this preference was stronger among individuals who were in poorer health, had lower education and income, and found it very difficult to afford the drugs they needed.<i>Conclusions.</i> The results suggest that Medicare beneficiaries could support policies that limit plan choice, as long as drug prices actually decrease.
Medical subject headings
- Drug Costs
- Medicare Part D
- Prescription Drugs